CALCRL and breast cancer: However, tumor growth of subcutaneously injected B16-F10 and LLC1 cells as well as orthotopically injected E0771 breast cancer cells was significantly decreased in EC-Calcrl-KO mice compared to control animals (Fig. 3, g and h; and Fig. S2 g).